Our partners

Industry partners

Specialising in the evaluation and regulated clinical investigations of novel medical devices, the SWaT Research Centre is a hub for industry partners seeking to evolve – and bring to market – wound care prevention and treatment devices.

Strong partnerships with clinical and academic institutions, close relationships with patients and patient advocacy groups, and the core of expertise that is the SWaT Network, make the Centre the ideal partner for companies working on outcome-focused healthcare, and the translation of scientific evidence into contemporary clinical decision-making and practice.

Tyndall National Institute

“Our participation in the work of the SWaT Research Centre is a very welcome expansion of Tyndall National Institute’s Deep Tech ICT for Health research programme. Among other interests in medtech, my team leads Tyndall’s activities in the development of next-generation ‘smart dressings’ – those that incorporate electronic functionalities to improve the care and management of chronic wounds. The SWaT Research Centre provides crucial access to key opinion leaders like Prof. Moore and her team – who guide the clinical development of this emerging technology – and to the expertise needed to validate our prototypes in clinically relevant settings.
Dr Conor O'Mahony, Senior Research Scientist, Tyndall National Institute

Clinical partners

Clinical partners are the cornerstone in the provision of patient care and the SWaT Research Centre works in close partnership with these key stakeholders. Together, we develop evidence-based solutions that transfer and directly relate to the improvement of clinical practice, patient care, and outcomes.

Maintaining a collaborative relationship is important to us, and we understand the mutual benefits and opportunities for improving research in the hospitals and staff development. Working together, we build better systems and guidelines, which positively influence the challenges within clinical practice, and enhance the lives of those who access the health service today and into the future.

Academic partners

We are committed to broadening the scope of expertise in wound care and tissue viability research. We work closely with specialists in this area, including biomedical scientists, health economists, and academic innovators worldwide. Our goal is to encourage partnerships that research and develop better practices for skin wound and trauma care, pushing the boundaries of research and ultimately saving lives.

With opportunities to increase publishing outputs, and the chance to collaborate on European and international projects, we welcome contact from academics who would be interested in joining us in our mission.

Patients/patient advocacy groups

The Centre is interested in examining patient outcomes through large-scale clinical studies. With figures suggesting that almost 5% of the population can be affected by a wound at any given time, we want to improve the quality of life for at-risk people. As a nurse-led Centre, we have a wealth of experience in tissue viability and wound care, pioneering research, epidemiological monitoring, and working with patients and their families in the management of wound prevention and treatment.

We welcome queries from clinical and academic partners, and patient advocacy groups. Please contact us directly swat@rcsi.com to learn more.

Debra International

"Our collaborations with Dr Declan Patton and Prof. Zena Moore have supported us in the development of a number of clinical practice guidelines (CPGs) in a rare, genetic skin condition, Epidermolysis bullosa (EB). They have offered support with the systematic literature searches, article appraisals, evidence summary tables and independent AGREE II appraisal of published CPGs. They also offer feedback support to ongoing panels at the recommendations and scientific writing of the manuscripts stages. We are delighted to continue this partnership and look forward to improving and standardising the CPGs development to improve clinical and social care for people living with EB worldwide."